bmuesli : News
Expanding Application Areas to Drive Growth in the Global Synthetic Biology Market, According to a New Report by Global Industry Analysts, Inc.
GIA announces the release of a comprehensive global report on Synthetic Biology. The global market for Synthetic Biology is projected to reach US$16.8 billion by 2020, driven by expanding commercial applications in end-use sectors such as energy, medicine, environment, agriculture and chemicals.
Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Synthetic Biology: A Global Strategic Business Report
San Jose, California (PRWEB) February 25, 2015
Follow us on LinkedIn ? Global interest in synthetic biology is driven by the technology?s promised potential to change society by bringing about a fundamental shift in the way energy, food and other industrial products are produced. In the field of healthcare, synthetic biology flaunts the potential to radically alter the way in which diseases are detected, prevented and cured. Synthetic biology is defined as engineered biology focused on the development of artificial, biologically inspired systems. In medical science, synthetic biology refers to the design and development of new biological organisms based on artificially created DNAs to design and develop new organisms or biochemical systems. This revolutionary branch of science brings together multiple disciplines such as computer modeling, engineering and biological sciences for creating next-generation biological systems, parts and devices.
Rapid advancements in DNA sequencing and synthesis are helping foster growth in the market. Computational modeling, DNA synthesis, and DNA sequencing, represent few of the major technologies that are playing key instrumental roles in pushing synthetic biology into the next stage of evolution. Commercial gene synthesis tools and pre-designed synbio tools are finding acceptance among molecular cloners. Synthetic biology based food ingredients are witnessing rapid commercialization, supported by the shifting focus on synbio ingredients in the global food supply chain.
Several of the leading chemical, energy, pharmaceutical, food, forestry and agribusiness companies are investing in synthetic biology research to develop new and potent products. Energy & Chemicals represents the largest as well as the fastest growing end-use market. Synthetic biology is opening new avenues for the scientific community to convert low-cost feedstock such as amino acids and sugars into fuels and medicines. The success of Genetically Modified (GM) seeds has opened up numerous opportunities for synthetic biology, with leading players in the sector investing substantial resources in developing a range of crops featuring enhanced nutritional value and pest protection. Additional applications in the area of agriculture include the development of new eco-friendly pesticides.
As stated by the new market research report on, Synthetic Biology, Europe represents the largest market worldwide, supported by high R&D interest in developing synthetic biology based products. Within Europe, Germany and the UK remain prominent markets. Asia-Pacific is forecast to emerge as the fastest-growing market with a projected CAGR of 41.9% over the analysis period.
Major players covered in the report include Agilent Technologies Inc., Amyris Inc., BP PLC, Chromatin Inc., Gevo Inc., 454 Life Sciences, Epoch Life Science Inc., Evolva SA, Solazyme Inc., Synthetic Genomics Inc., Synthetic Biologics Inc., DNA2.0, and Intrexon Corp, among others.
The research report titled "Synthetic Biology: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, drivers, issues, and strategic industry activities of major companies worldwide. The report provides market estimates and projections for geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, and Rest of Europe), Asia-Pacific and Rest of World. The report analyzes the global market for synthetic biology by the following end-use sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others.
For more details about this comprehensive market research report, please click here
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/